Treatment of Hyperammonemia in Liver Failure: A Tale of Two Enzymes
No abstract is available. To read the body of this article, please view the Full Text online.
Conflicts of interest The authors disclose the following: Professor Rajiv Jalan (University College London) has filed for patents surrounding the use of l-ornithine phenylacetate for the treatment of hepatic encephalopathy. The technology has been licensed to Ocera Therapeutics. William M. Lee discloses no conflicts.
PII: S0016-5085(09)00561-7
doi:10.1053/j.gastro.2009.04.016
© 2009 Published by Elsevier Inc.
Refers to article:
-

Efficacy of L-Ornithine L-Aspartate in Acute Liver Failure: A Double-Blind, Randomized, Placebo-Controlled Study
, 23 February 2009

